Literature DB >> 15700214

Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.

B Jüngling1, I Kindermann, C Moser, W Püschel, K W Ecker, H J Schäfers, M Böhm, S Zeuzem, T Giese, A Stallmach.   

Abstract

BACKGROUND: Cardiac transplantation has become an accepted treatment modality for end-stage heart failure. Immunosuppressive agents, which are used after transplantation, are considered as therapeutic options for inflammatory bowel disease. CASE REPORT: We report on a 53-year-old patient who was treated for 2 years with cyclosporine A, azathioprine and prednisolone after heart transplantation. He developed a distal colitis with all features of ulcerative colitis. An infectious or ischemic etiology was carefully excluded. In spite of high-dose treatment with prednisolone the patient's abdominal symptoms worsened and he developed a progression of the inflammation in the entire colon and a colectomy with ileostomy was necessary. The histology was consistent with ulcerative colitis. After colectomy he recovered and remained in a good state of health.
CONCLUSIONS: This report supports the concept that new onset inflammatory bowel disease can develop in a heart transplantation recipient in spite of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700214     DOI: 10.1055/s-2004-813743

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  2 in total

Review 1.  Clinical management of inflammatory bowel disease in the organ recipient.

Authors:  Amedeo Indriolo; Paolo Ravelli
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

2.  Ulcerative Colitis Following Orthotopic Cardiac Transplantation.

Authors:  Anahita Sadeghi; Pouya Bastani; Mehdi Mohamadnejad
Journal:  Middle East J Dig Dis       Date:  2017-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.